Search research articles
Contact Us
Filters
Showing results (11-20 of 24) with videos related to
Page
of 3
Sort By:
Scientific Reports
|
December 15, 2020
Integrative analysis of multi-platform reverse-phase protein array data for the pharmacodynamic assessment of response to targeted therapies
Adam Byron, Stephan Bernhardt, Bérèngere Ouine, et al.
Exploration of Targeted Anti-Tumor Therapy
|
April 20, 2022
Collateral-resistance to estrogen and HER-activated growth is associated with modified AKT, ERα, and cell-cycle signaling in a breast cancer model
Kate M Moore, Vera Cerqueira, Kenneth G MacLeod, et al.
Development (Cambridge, England)
|
October 12, 2019
N-cadherin stabilises neural identity by dampening anti-neural signals
Karolina Punovuori, Rosa P Migueles, Mattias Malaguti, et al.
Nature Communications
|
February 14, 2014
Extracellular palladium-catalysed dealkylation of 5-fluoro-1-propargyl-uracil as a bioorthogonally activated prodrug approach
Jason T Weiss, John C Dawson, Kenneth G Macleod, et al.
Disease Models & Mechanisms
|
January 30, 2021
NODAL/TGFβ signalling mediates the self-sustained stemness induced by PIK3CAH1047R homozygosity in pluripotent stem cells
Ralitsa R Madsen, James Longden, Rachel G Knox, et al.
The Journal of Allergy and Clinical Immunology
|
February 12, 2018
Mer-mediated eosinophil efferocytosis regulates resolution of allergic airway inflammation
Jennifer M Felton, Christopher D Lucas, David A Dorward, et al.
Oncogene
|
September 24, 2021
ISGylation drives basal breast tumour progression by promoting EGFR recycling and Akt signalling
Alfonso Bolado-Carrancio, Martin Lee, Ailith Ewing, et al.
Cell Death Discovery
|
March 23, 2017
Global histone modification fingerprinting in human cells using epigenetic reverse phase protein array
Marina Partolina, Hazel C Thoms, Kenneth G MacLeod, et al.
Oncotarget
|
February 18, 2016
Identification of novel pathways linking epithelial-to-mesenchymal transition with resistance to HER2-targeted therapy
Helen Creedon, Laura Gómez-Cuadrado, Žygimantė Tarnauskaitė, et al.
Cancer Research
|
August 21, 2021
A Conformation Selective Mode of Inhibiting SRC Improves Drug Efficacy and Tolerability
Carolin Temps, Daniel Lietha, Emily R Webb, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 24) with videos related to
Sort By:
Page
of 3
Scientific Reports
|
December 15, 2020
Integrative analysis of multi-platform reverse-phase protein array data for the pharmacodynamic assessment of response to targeted therapies
Adam Byron, Stephan Bernhardt, Bérèngere Ouine, et al.
Exploration of Targeted Anti-Tumor Therapy
|
April 20, 2022
Collateral-resistance to estrogen and HER-activated growth is associated with modified AKT, ERα, and cell-cycle signaling in a breast cancer model
Kate M Moore, Vera Cerqueira, Kenneth G MacLeod, et al.
Development (Cambridge, England)
|
October 12, 2019
N-cadherin stabilises neural identity by dampening anti-neural signals
Karolina Punovuori, Rosa P Migueles, Mattias Malaguti, et al.
Nature Communications
|
February 14, 2014
Extracellular palladium-catalysed dealkylation of 5-fluoro-1-propargyl-uracil as a bioorthogonally activated prodrug approach
Jason T Weiss, John C Dawson, Kenneth G Macleod, et al.
Disease Models & Mechanisms
|
January 30, 2021
NODAL/TGFβ signalling mediates the self-sustained stemness induced by PIK3CAH1047R homozygosity in pluripotent stem cells
Ralitsa R Madsen, James Longden, Rachel G Knox, et al.
The Journal of Allergy and Clinical Immunology
|
February 12, 2018
Mer-mediated eosinophil efferocytosis regulates resolution of allergic airway inflammation
Jennifer M Felton, Christopher D Lucas, David A Dorward, et al.
Oncogene
|
September 24, 2021
ISGylation drives basal breast tumour progression by promoting EGFR recycling and Akt signalling
Alfonso Bolado-Carrancio, Martin Lee, Ailith Ewing, et al.
Cell Death Discovery
|
March 23, 2017
Global histone modification fingerprinting in human cells using epigenetic reverse phase protein array
Marina Partolina, Hazel C Thoms, Kenneth G MacLeod, et al.
Oncotarget
|
February 18, 2016
Identification of novel pathways linking epithelial-to-mesenchymal transition with resistance to HER2-targeted therapy
Helen Creedon, Laura Gómez-Cuadrado, Žygimantė Tarnauskaitė, et al.
Cancer Research
|
August 21, 2021
A Conformation Selective Mode of Inhibiting SRC Improves Drug Efficacy and Tolerability
Carolin Temps, Daniel Lietha, Emily R Webb, et al.
Page
of 3